|
Post by ltta on Sept 26, 2019 19:56:03 GMT -5
I may be confused, but is this maybe it? No publicly available results, just an informal announcement as below: In the last earnings call (August 7), Castagna said: "United Therapeutics is going very nicely ... We anticipate achieving our second milestone with $12.5 million in the second half of 2019. The research agreement for the undisclosed PH compound is substantially complete. We expected decision with United Therapeutics in Q3." I believe Spencer is assuming the secret compound is Adcirca (aka Tadalafil). I'm not sure / do not recall whether that has been officially confirmed. The transcript is available on SA if you are a paying member, otherwise you can search google for a cached copy. But IIRC it doesn't say anything more on the subject than what I quoted above. I'm not a member but I can get it. Try this... seekingalpha.com/article/4283046-mannkind-corporation-mnkd-ceo-michael-castagna-q2-2019-results-earnings-call-transcript?part=singleOMG brentie! Where do you find your avatars! Love it.
|
|